论文信息 - S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE - 字舞流文

S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE

M. Mauro | A. Hochhaus | N. Chaudhri | S. Kapoor | P. le Coutre | S. Saussele | D. Réa | M. Annunziata | L. Fogliatto | K. Sasaki | S. Quenet | Y. Minami | A. Turkina | Jordi Cortés | E. Lomaia | C. Boquimpani | J. Apperley | T. Hughes | V. Bédoucha | D. Kim | S. Voloshin | A. Allepuz | V. García‐Gutiérrez | A. Abdo | D. Kim | L. Chee